AVEN Antikörper (AA 301-362) (AbBy Fluor® 647)
-
- Target Alle AVEN Antikörper anzeigen
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Bindungsspezifität
- AA 301-362
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AVEN Antikörper ist konjugiert mit AbBy Fluor® 647
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human,Mouse,Rat,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human AVEN
- Isotyp
- IgG
- Top Product
- Discover our top product AVEN Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Andere Bezeichnung
- Aven (AVEN Produkte)
- Synonyme
- AVEN antikoerper, pdcd12 antikoerper, aven antikoerper, wu:fc08c09 antikoerper, si:ch211-150c22.4 antikoerper, PDCD12 antikoerper, 1700013A01Rik antikoerper, 1700056A21Rik antikoerper, mAven-L antikoerper, mAven-S antikoerper, apoptosis and caspase activation inhibitor antikoerper, apoptosis, caspase activation inhibitor L homeolog antikoerper, apoptosis, caspase activation inhibitor antikoerper, Aven antikoerper, AVEN antikoerper, aven.L antikoerper, aven antikoerper
- Hintergrund
-
Synonyms: 1700013A01Rik, 1700056A21Rik, mAven L, mAven S, MGC124011, Apoptosis caspase activation inhibitor, Cell death regulator Aven, OTTMUSP00000016129, PDCD12, Programmed cell death 12, RP23-52C15.2, AVEN_HUMAN
Background: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. AVEN is a recently discovered protein that blocks apoptosis induced by Apaf-1 and caspase-9. It is thought that AVEN functions by binding to Bcl-xL, an antiapoptotic member of the Bcl-2 family, and to Apaf-1, possibly interfering with the ability of Apaf-1 to self-associate, suggesting that AVEN impedes Apaf-1-mediated caspase activation. Higher levels of AVEN mRNA are seen in patients with acute leukemia than in control patients, suggesting that AVEN may be useful as a prognostic indicator in leukemia patients.
- Gen-ID
- 57099
-